6VJT

Co-crystals of broadly neutralizing antibody with the linear epitope from Hepatitis B surface antigen


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.78 Å
  • R-Value Free: 0.227 
  • R-Value Work: 0.182 
  • R-Value Observed: 0.183 

wwPDB Validation   3D Report Full Report

Currently 6VJT does not have a validation slider image.


This is version 1.2 of the entry. See complete history


Literature

A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations.

Wang, Q.Michailidis, E.Yu, Y.Wang, Z.Hurley, A.M.Oren, D.A.Mayer, C.T.Gazumyan, A.Liu, Z.Zhou, Y.Schoofs, T.Yao, K.H.Nieke, J.P.Wu, J.Jiang, Q.Zou, C.Kabbani, M.Quirk, C.Oliveira, T.Chhosphel, K.Zhang, Q.Schneider, W.M.Jahan, C.Ying, T.Horowitz, J.Caskey, M.Jankovic, M.Robbiani, D.F.Wen, Y.de Jong, Y.P.Rice, C.M.Nussenzweig, M.C.

(2020) Cell Host Microbe 28: 335-349.e6

  • DOI: https://doi.org/10.1016/j.chom.2020.05.010
  • Primary Citation of Related Structures:  
    6VJT

  • PubMed Abstract: 

    Although there is no effective cure for chronic hepatitis B virus (HBV) infection, antibodies are protective and correlate with recovery from infection. To examine the human antibody response to HBV, we screened 124 vaccinated and 20 infected, spontaneously recovered individuals. The selected individuals produced shared clones of broadly neutralizing antibodies (bNAbs) that targeted 3 non-overlapping epitopes on the HBV S antigen (HBsAg). Single bNAbs protected humanized mice against infection but selected for resistance mutations in mice with prior established infection. In contrast, infection was controlled by a combination of bNAbs targeting non-overlapping epitopes with complementary sensitivity to mutations that commonly emerge during human infection. The co-crystal structure of one of the bNAbs with an HBsAg peptide epitope revealed a stabilized hairpin loop. This structure, which contains residues frequently mutated in clinical immune escape variants, provides a molecular explanation for why immunotherapy for HBV infection may require combinations of complementary bNAbs.


  • Organizational Affiliation

    Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China. Electronic address: wangqiao@fudan.edu.cn.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Heavy Chain Fab Fragment of Monoclonal Ab15A [auth H]225Homo sapiensMutation(s): 0 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 2
MoleculeChains Sequence LengthOrganismDetailsImage
Light Chain Fab Fragment of Monoclonal antibody A15B [auth L]215Homo sapiensMutation(s): 0 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
  • Reference Sequence

Find similar proteins by:  Sequence   |   3D Structure  

Entity ID: 3
MoleculeChains Sequence LengthOrganismDetailsImage
antigenic region 139-148 of Hepatitis B surface antigen proteinC [auth P]11Hepatitis B virusMutation(s): 0 
UniProt
Find proteins for A0A5A4RHH5 (hepatitis B virus genotype C)
Explore A0A5A4RHH5 
Go to UniProtKB:  A0A5A4RHH5
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupA0A5A4RHH5
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.78 Å
  • R-Value Free: 0.227 
  • R-Value Work: 0.182 
  • R-Value Observed: 0.183 
  • Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 49.848α = 90
b = 71.15β = 90
c = 134.704γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
XDSdata scaling
PHASERphasing

Structure Validation

View Full Validation Report

Currently 6VJT does not have a validation slider image.



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United StatesPHS AI129795

Revision History  (Full details and data files)

  • Version 1.0: 2020-08-26
    Type: Initial release
  • Version 1.1: 2022-03-16
    Changes: Author supporting evidence, Database references
  • Version 1.2: 2023-10-11
    Changes: Data collection, Refinement description